Nature1 年
Enabling T cell therapy for established solid tumors using genetic-enhancing modifiers
Achelois BioPharma has focused on discovering T cell-intrinsic genetic-enhancing modifiers (GEMs) since the company was founded in 2015. Achelois scientists postulated that during normal immune ...
Nature1 年
Variant-resistant therapeutics for pandemic viruses
To this end, Achelois BioPharma developed variant-resistant antivirals with unique antiviral mechanisms to pre-empt future pandemics. Scientists at Achelois have been pondering the unique ...